Skip to Main Content

E. Jennifer Edelman, MD, MHS

Associate Professor of Medicine (General Medicine) and of Social and Behavioral Sciences

Contact Information

E. Jennifer Edelman, MD, MHS

Patient Care Locations

Mailing Address

  • General Internal Medicine

    PO Box 208056

    New Haven, CT, 06520-8025

    United States

Appointments

Biography

E. Jennifer Edelman, MD, MHS is an Associate Professor of Medicine and Public Health. Certified as an internist, HIV specialist and in Addiction Medicine, she serves as an HIV provider and the physician consultant in the Addiction Medicine Treatment Program at the Yale-New Haven Hospital HIV Clinic. Her research focuses on optimizing HIV prevention and treatment in the context of substance use, including opioid, alcohol and tobacco use. To this end and applying a range of methodologies, she leads and collaborates on NIH-funded projects to evaluate novel and implement evidence-based addiction treatment in medical settings, especially HIV treatment settings. In addition, her work has focused on understanding harms associated with opioid use among people with HIV. She collaborates with community-based and public health partners to promote HIV prevention, including use of pre-exposure prophylaxis (PrEP). She mentors trainees, including post-doctoral fellows and public health students, and is Associate Director of the Research on Addiction Medicine Scholars (RAMS) Program. She regularly serves on NIH grant review committees and is on the editorial board of several peer-reviewed journals.

Education & Training

  • MHS
    Yale University (2012)
  • MD
    Columbia University (2005)
  • BS
    Cornell University, Human Development and Family Studies; and Human Biology, Health (1999)
  • Chief Resident
    Yale-New Haven Hospital
  • Residency
    Yale-New Haven Hospital
  • Intern
    Yale-New Haven Hospital
  • Board Certification
    American Academy of HIV Medicine, HIV Specialist (2013)
  • Board Certification
    AB of Internal Medicine, Internal Medicine (2009, recertified: 2019)

Activities

  • Promoting Emergency Department-Initiated Buprenorphine: What are Barriers and Facilitators among Prescribers?
    New Haven, United States 2020
  • Invited panelist, Examination of Integration of Opioid and Infectious Disease Prevention Efforts in Select Programs
    Washington, United States 2019
  • Invited speaker, Adaptive and Integrated Pharmacological Interventions, Stepped Care
    Minneapolis, United States 2019
  • Racial Differences in Alcohol and Other Substance Use among MSM: Implications for HIV Prevention
    Bethesda, United States 2019
  • Trajectories of self-reported illicit opioid use among people living with HIV
    San Antonio, United States 2019
  • Integrated Stepped Care to Address Alcohol Use among Patients Living with HIV and Alcohol Use Disorder: Results from a Randomized Controlled Clinical Trialile.
    Santiago, Chile 2018
  • Unhealthy Alcohol Use among Patients with HIV: Reversing the Trends
    Moran, United States 2018
  • The Opioid Crisis Panel
    New Haven, United States 2018
  • Reducing Harms from the Opioid Epidemic: The Role of Pharmacists and Pharmacy Technicians
    Cromwell, United States 2018
  • Trajectories of Non-Medical Use of Prescription Opioids Among People Living With HIV
    Denver, United States 2018
  • Alcohol Behavioral Research and HIV PrEP in Primary Care
    Bethesda, United States 2017
  • If You Build It, They Sometimes Come: Use of Integrated Stepped Care Services for Unhealthy Alcohol use in HIV clinics
    Washington, United States 2017
  • Using Phosphatidylethanol (PEth) to Validate Unhealthy Alcohol Use in Non-Treatment Seeking HIV-Positive Patients Entering Clinical Trials
    Denver, United States 2017
  • The Impact of Injectable Naltrexone on Antiretroviral Therapy Adherence, HIV Viral Load and Drinking in HIV-Positive Heavy Drinkers
    Denver, United States 2017
  • Do Prescribed Opioids Increase Risk of Community-Acquired Pneumonia Requiring Hospitalization?
    Washington, United States 2017
  • The Prevalence and Impact of Unhealthy Alcohol Use Among Men Who Have Sex With Men Initiating Pre-Exposure Prophylaxis for HIV Infection: A Pilot Study
    Washington, United States 2017
  • Working with HIV Clinics to Adopt Addiction Treatments Using Implementation Facilitation (WHAT-IF?): Initial Lessons Learned
    Seattle, United States 2017
  • The Opioid Crisis: Where are We and What Can We Do?
    Toronto, Canada 2016
  • Integrated Stepped Care for Unhealthy Alcohol Use in HIV Clinics
    Lausanne, Switzerland 2016
  • Improving PrEP Update: A Need for Implementation Science
    New York, United States 2016
  • Integrating Addiction Treatment and HIV Care: the Role of Implementation Science
    New York, United States 2016
  • Update in HIV Medicine: Turning the Tide on the Epidemic
    Hollywood, United States 2016
  • Getting HIV Pre-Exposure Prophylaxis (PrEP) into Primary Care Practice: Train All Providers, Designate an On-Site PrEP Specialist, or Refer Out?
    Hollywood, United States 2016
  • Ending HIV with PrEP: The Newest HIV Prevention Tool for Primary Care
    Hollywood, United States 2016
  • Improving HIV Diagnosis and Prevention: The Role of Community-Based Participatory Research Principles
    Springfield, United States 2015
  • HIV and Alcohol
    New Haven, United States 2015
  • Hepatitis C and HIV and Opioid Use Disorder
    New Haven, United States 2015
  • Implementing Integrated Stepped Care for Unhealthy Alcohol Use in HIV Treatment Settings: A Qualitative Study using the CFIR Constructs
    Washington, United States 2015
  • Implementing Integrated Stepped Care for Unhealthy Alcohol Use in HIV Treatment Settings: A Qualitative Study using the CFIR Constructs.
    San Antonio, United States 2015
  • Do Prescribed Opioids Impact CD4 Count Restoration among HIV-infected Patients Initiating Antiretroviral Therapy?”
    Phoenix, United States 2015
  • Is Opioid Use associated with T Cell Dysfunction?
    Phoenix, United States 2015
  • HIV-Related Stigma and Substance Use in a Russian Cohort of HIV-infected Risky Drinkers
    Phoenix, United States 2015
  • Is Excess Medication associated with Mortality among HIV+ and Uninfected Patients?
    Toronto, Canada 2015
  • Do Prescribed Opioids Impact CD4 Count Restoration among HIV+ Patients Initiating Antiretroviral Therapy?
    Toronto, Canada 2015
  • A Complex Interplay between Social Isolation, Stigma and Substance Use: Results from a Qualitative Study
    San Francisco, United States 2015
  • Is Unhealthy Alcohol Use Associated with CD4 Cell Count among HIV-infected Patients On and Off Combination Antiretroviral Therapy?
    Washington, United States 2014
  • The Impact of Prescription Opioids on CD4 Count in HIV: A Longitudinal Analysis
    San Juan, Puerto Rico 2014
  • Is Unhealthy Alcohol Use Associated with CD4 Cell Count Among HIV-Infected Patients On and Off Combination Antiretroviral Ttherapy?
    Washington, United States 2014
  • Upside and Challenges of Being an Early Career Research Faculty Member
    Boston, United States 2013
  • HIV+ Individuals on ART Are At Risk of Polypharmacy: More Medication Increases Mortality
    San Francisco, United States 2013
  • HIV Testing and Sexual Risk Reduction Counseling in Office-Based Buprenrophine/Naloxone Treatment
    San Diego, United States 2013
  • HIV update
    Denver, United States 2013
  • Polypharmacy Among Veterans With and Without HIV Infection in the Veterans Aging Cohort Study
    Denver, United States 2013
  • Acetaminophen Receipt Among HIV-Infected Patients with Advanced Hepatic Fibrosis
    Denver, United States 2013
  • Partner Notification Practices Among HIV-Infected Men
    Denver, United States 2013
  • HIV Status is An Independent Predictor of Receiving Opioid Analgesics
    Orlando, United States 2012
  • Improving Partner Notification: A Qualitative Study of Medical Case Managers,Disease Intervention Specialists and Men Who Have Sex With Men
    Orlando, United States 2012
  • The Impact of Buprenorphine/Naloxone Treatment on HIV Risk Behaviors Among HIV-Infected, Opioid-Dependent Patients: Results From the BHIVES Collaboration
    Orlando, United States 2012
  • Partner Notification: A Qualitative Study of Medical Case Managers, Disease Intervention Specialists and Men Who Have Sex With Men
    Minneapolis, United States 2012
  • Project COACH: Counseling Others About Contacts and Exposures with HIV
    Washington, United States 2011
  • Project ART-ED: Alcohol reduction and HIV testing in the Emergency Department
    Boston, United States 2011
  • Prescription Opioids Among HIV-Infected and Uninfected Veterans
    Washington, United States 2011
  • Project ART-ED: Alcohol Reduction and HIV Testing in the Emergency Department
    Phoenix, United States 2011
  • Symptoms on EFV/FTC/TDF vs. Other cART Regimens”
    Phoenix, United States 2011
  • Symptoms on Atripla vs. Other cART
    Atlanta, United States 2010
  • Patient and Provider-Reported Symptoms in the cART Era
    Minneapolis, United States 2010
  • Opiates for Chronic Pain: A Rational Approach for the Primary Care Provider
    Providence, United States 2010

Honors & Recognition

AwardAwarding OrganizationDate
Locally-Initiated Project Funding Award: “Prescription Opioid Tapering: Trajectories Among Men and Women Veterans”Veterans Affairs2019
Award for Excellence in Clinical InvestigationNew England Society of General Internal Medicine (SGIM)2018
Research Award: “Optimizing HIV Prevention Among MSM Prescribed PrEP with Heavy Alcohol Use: A qualitative study to examine acceptability of ‘PrEP-STEPs"Fund for Lesbian and Gay Studies (FLAGS)2018
Best ReviewerAnnals of Internal Medicine2018
Best ReviewerPharmacoepidemiology and Drug Safety2016
Editorial FellowshipJournal of Substance Abuse Treatment2015
Early Career Investigator Travel Award (to the 2014 College on Problems of Drug Dependence Annual Meeting)National Institute on Drug Abuse (NIH)2014
Travel Award (to the 8th International Annual INEBRIA Conference)National Institute on Drug Abuse (NIH)2011
Lawrence Linn AwardSociety of General Internal Medicine2010
Frederick L. Sachs AwardFrederick L. Sachs2008
Humanism in Medicine AwardLeonard Tow2005
Glasgow-Rubin Achievement AwardAmerican Medical Women's Association (AMWA)2005
Honor Society MemberAlpha Omega Alpha Honor Society2005
Honor Society MemberArnold P. Gold Humanism in Medicine Honor Society2005
Dr. Robert A. Savitt & Dr. George D. McCormack AwardDr. Robert A. Savitt & Dr. George D. McCormack2005

Professional Service

OrganizationRoleDate
Yale School of Public Health, Center for Interdisciplinary Research on AIDS, Clinical Health Services and Research CoreDirector2020 - Present
Special Emphasis Panel Review Committee for Member Conflicts for AIDS and Related ResearchReviewer2020 - Present
Yale Physician Associate Program Thesis Readers’ CommitteeCommittee Member2019
Healthcare Deliveries and Methodologies Member Conflict Study Section, NIH/Center for Scientific Research.Reviewer2019
Special Emphasis Panel Review Committee for “PAR18-222: Multi-site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01)” and “PAR18-223: Multi-Site Pilot & Feasibility Studies for System-Level Implementation of Substance Use Prevention and Treatment Services"Reviewer2019
Special Emphasis Panel Review Committee for “RFA-DA-19-013: Responding to Opioid Use Disorders (OUD) in Tribal Communities in the Context of SAMHSA Funding”Reviewer2019
Journal of General Internal Medicine, Deputy EditorEditor2019 - Present
Society of General Internal Medicine, Best Paper, National Annual MeetingReviewer2018 - 2020
“PAR-16-055: Mechanism for Time-Sensitive Drug Abuse Research (R21),” NIH/NIDAReviewer2018
American Academy of HIV Medicine New England Steering CommitteeMember2018 - Present
Data and Safety Monitoring Board, Yale Psychotherapy Development CenterBoard Member2017 - 2020
Yale Physician Associate Program Thesis Readers’ CommitteeCommittee Member2017
Special Emphasis Panel for “Advancing Exceptional Research on HIV/AIDS and Substance Abuse (R01)”, NIH/NIDAReviewer2017
Special Emphasis Panel for “HIV, HCV and Related Comorbidities in Rural Communities Affected by Opioid Injection Drug Epidemics in the United States: Building Systems for Prevention, Treatment and Control (UG3/UH3)”, NIH/NIDAReviewer2017
Veterans Health Administration, Sexually Transmitted Infections (STI) Screening and Resources for the Primary Care of Veterans with HIV ManualReviewer2017
Addiction Science and Clinical PracticeAssociate Editor2017 - Present
Addiction Science and Clinical Practice, Special Issue Co-EditorEditor2017 - Present
American College of Physicians, American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients with Alcohol Use DisorderReviewer2017 - Present
Yale University Traditional Medicine Residency Program, MAC (Mentor, Advisor, Coach) for ResidentsMentor2016 - 2020
Journal of Substance Abuse Treatment, Editorial Board MemberEditor2016 - Present
College on Problems of Drug DependenceMember2016 - Present
Journal of Substance Abuse Treatment, Editorial FellowEditor2015 - 2016
Special Emphasis Panel for “Centers for AIDS Research and Developmental Centers for AIDS Research”, NIH/NIAIDReviewer2014
Infectious Disease Society, 2014 HIVMA of IDSA Clinical Practice Guideline for the Management of Chronic Pain in Patients Infected with HIVReviewer2014
Polypharmacy Workgroup, Veterans Aging Cohort Study, Yale University/West Haven VA Connecticut Healthcare SystemCo-Chair2013 - 2019
Society of General Internal Medicine, HIV Interest GroupCo-Chair2013 - 2019
Yale Physician Associate Program Thesis Readers’ CommitteeCommittee Member2013
Special Emphasis Panel for “Clinical Trials Units for NIAID Networks (UM1)”, NIH/NIAIDReviewer2013
Pilot Project Review Committee, Center for Interdisciplinary Research on AIDS, Yale UniversityReviewer2013
Society of General Internal Medicine, New England Regional Annual Meeting, Abstract ReviewerReviewer2013 - Present
Yale University Traditional Medicine Residency Program, Intern Selection CommitteeCommittee Member2012 - 2017
Society of General Internal Medicine, National Annual Meeting, Abstract ReviewerReviewer2012 - 2016
Community Research Partnership Program Grant Review Committee, Center for Interdisciplinary Research on AIDS, Yale UniversityReviewer2012
AIDS Project New Haven, City of New HavenBoard Member2012 - Present
Society of General Internal Medicine, Alcohol, Tobacco, and Other Drug (ATOD) Use Interest GroupMember2012 - Present
Ryan White FY2011 Proposal Review CommitteeMember2011
Opioids Workgroup, Veterans Aging Cohort Study, Yale University/West Haven VA Connecticut Healthcare SystemCo-Chair2011 - Present
CT HIV/AIDS Identification and Referral Task ForceMember2010 - 2018
Yale School of Public Health, Center for Interdisciplinary Research on AIDS, Community Research Implementation CoreMember2010 - Present
Yale School of Public Health, Center for Interdisciplinary Research on AIDS, Clinical Health Services and Research CoreMember2010 - Present
Yale School of Public Health, Center for Interdisciplinary Research on AIDS, Clinical Workgroup, Multi-level HIV Intervention Network Trial (MHINT)Develop the clinical improvement and interventions2009 - 2010

Departments & Organizations